Keywords: gsk, aims, raise, czech, market, share, glaxosmithkline
GSK aims to raise Czech market share
Article | 29 April 2002
GlaxoSmithKline is aiming to increase its share of the Czech Republic'spharmaceutical market from the current 4.6% to 5% this year, according to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
